DISHMAN CARBOGEN AMCIS
Back to Balance Sheet
|
DISHMAN CARBOGEN AMCIS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,925 Cr | ₹2,555 Cr | ₹1,798 Cr | ₹1,420 Cr | ₹1,290 Cr |
What is the latest Total Current Liabilities ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,925 Cr |
| Mar2024 | ₹2,555 Cr |
| Mar2023 | ₹1,798 Cr |
| Mar2022 | ₹1,420 Cr |
| Mar2021 | ₹1,290 Cr |
How is Total Current Liabilities of DISHMAN CARBOGEN AMCIS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,925 Cr | -24.66 | |
| Mar2024 | ₹2,555 Cr | 42.06 | |
| Mar2023 | ₹1,798 Cr | 26.67 | |
| Mar2022 | ₹1,420 Cr | 10.04 | |
| Mar2021 | ₹1,290 Cr | - | |
Compare Total Current Liabilities of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,775.4 Cr | -0.1% | -5.7% | -32.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | -0.1% |
-5.7% |
-32.4% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses